Aldeyra Therapeutics Inc Share Price Today: Live Updates & Key Insights
Aldeyra Therapeutics Inc share price today is $1.49, up -1.94%. The stock opened at $1.6 against the previous close of $1.55, with an intraday high of $1.6 and low of $1.48.
Aldeyra Therapeutics Inc Share Price Chart
Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc Share Price Performance
Aldeyra Therapeutics Inc Institutional Holdings
Aldeyra Therapeutics Inc Market Status
Aldeyra Therapeutics Inc Fundamentals
Market Cap 93.50 M
PB Ratio 2.4396
PE Ratio 0.0
Enterprise Value 53.06 M
Total Assets 72.06 M
Volume 1126283
Aldeyra Therapeutics Inc Company Financials
About Aldeyra Therapeutics Inc & investment objective
Company Information Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Organisation Biotechnology
Employees 7
Industry Biotechnology
CEO Dr. Todd C. Brady M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Aldeyra Therapeutics Inc FAQs
What is the share price of Aldeyra Therapeutics Inc today?
The current share price of Aldeyra Therapeutics Inc is $1.49.
Can I buy Aldeyra Therapeutics Inc shares in India?
Yes, Indian investors can buy Aldeyra Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Aldeyra Therapeutics Inc shares in India?
You can easily invest in Aldeyra Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Aldeyra Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Aldeyra Therapeutics Inc.
Can I buy fractional shares of Aldeyra Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Aldeyra Therapeutics Inc?
Aldeyra Therapeutics Inc has a market cap of $93.50 M.
In which sector does Aldeyra Therapeutics Inc belong?
Aldeyra Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Aldeyra Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Aldeyra Therapeutics Inc?
The PE ratio of Aldeyra Therapeutics Inc is N/A and the PB ratio is 2.44.